Posterior Reversible Encephalopathy Syndrome (PRES) in Rheumatic Autoimmune Disease

  • Izzat Khanjar Rheumatology Department, Hamad Medical Corporation, Doha, Qatar
  • Ibrahim Abdulmomen Rheumatology Department, Hamad Medical Corporation, Doha, Qatar
  • Yousef Yahia Rheumatology Department, Hamad Medical Corporation, Doha, Qatar
  • Abdul-Wahab Al-Allaf Rheumatology Department, Hamad Medical Corporation, Doha, Qatar

Keywords

PRES, posterior reversible encephalopathy syndrome, rheumatic autoimmune disease

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinical-radiological entity with many causes. The primary abnormality is cerebral vasogenic oedema. Here we describe the management of five patients with PRES syndrome who presented to our hospital.

References

  • Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500.

  • Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic oedema. AJNR Am J Neuroradiol 2008;29:1043–1049.

  • Casey SO, Sampaio RC, Michel E, et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21:1199–1206.

  • McKinney AM, Short J, Truwit CL et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Roentgenol 2007;189:904–912.

  • Vincent JL (ed). Annual update in intensive care and emergency medicine 2011. New York: Springer, 813 pp.

  • Rahmanzadeh R, Rahmanzade R, Zabihiyeganeh M. Posterior reversible encephalopathy syndrome in a patient with mixed connective tissue disease: a case report. J Med Case Rep 2016;10:145.

  • Burnett MM, Hess CP, Roberts JP, et al. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 2010;112:886–889.

  • Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010;85:427–432.

  • Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379–383.

  • Striano P, Striano S, Tortora F, et al. Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit 2005;11:CR549–53.

  • Abe T, Tokuda Y. Recurrent posterior reversible encephalopathy syndrome of the brainstem in a hypertensive patient with end-stage renal disease. J Emerg Trauma Shock 2014;7:242–243.

  • Roy S, Gandhi AK, Jana M, Julka PK. Recurrent posterior reversible encephalopathy syndrome after chemotherapy in hematologic malignancy-posterior reversible encephalopathy syndrome can strike twice!!! J Cancer Res Ther 2014;10:393–396.
  • Published: 2018-03-27

    Issue: Vol 5 No 6 (view)

    Section: Articles

    How to cite:
    Khanjar, I., Abdulmomen, I., Yahia, Y., & Al-Allaf, A.-W. (2018). Posterior Reversible Encephalopathy Syndrome (PRES) in Rheumatic Autoimmune Disease. European Journal of Case Reports in Internal Medicine, 5(6). https://doi.org/https://doi.org/10.12890/2018_000866